Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mellitus and improve risk stratification: a prospective cohort study - PubMed
3 hours ago
- #pancreatic cancer
- #metabolomics
- #type 2 diabetes
- T2DM increases pancreatic cancer risk by 40% over 13.6 years.
- 30 metabolites, mainly linked to lipid dysregulation and inflammation, explain much of this risk.
- A Metabolic Risk Score based on these metabolites improves long-term risk prediction.